General Anxiety Disorder
Conditions
Brief summary
This study investigates a new delivery method for the General Anxiety Disorder - 7 (GAD 7), a clinically accepted tool for diagnosing general anxiety disorder. The new tool records auditory responses to the assessment and the study will examine if the instrument is effective at capturing participant depression levels. If proven effective, future studies may investigate if the new format can be used to improve at home clinical care.
Detailed description
This study is an investigation of the construct validity and user experience of a new delivery system for the General Anxiety Disorder - 7 (GAD 7), a clinically accepted tool for diagnosing general anxiety disorder. The purpose of the study is to examine if the new delivery system of the GAD 7 is effective at capturing participant anxiety levels and to assess the differences of usability between the paper and voice administered versions. The voice administered version uses a Mirror device, which is similar to a smart television with a mirror interface. The device records auditory responses to the GAD 7 through Amazon Alexa. The investigators will be comparing the responses on the new device to those given on the clinically established paper format. If proven effective at capturing depression levels of patients, future studies may investigate if the new format can be used to improve at home clinical care.
Interventions
DIAGNOSTIC_TESTPaper GAD 7
The paper based GAD 7 that is commonly accepted at clinics
DIAGNOSTIC_TESTVoice Administered GAD 7
This is the voice based GAD 7 that is administered through a Mirror device equipped with Amazon Alexa software.
Sponsors
Oral Roberts University
Oklahoma State University Center for Health Sciences
Study design
Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
DIAGNOSTIC
Masking
NONE
Intervention model description
This study will be a repeated measure, mixed methods design (i.e., it will contain both qualitative and quantitative components). Newly admitted patients will be asked to complete the questionnaires (i.e., GAD 7 and the UEQ) at two different time points (i.e., Baseline and 1-month follow-up). In order to reduce or control for order effects, the procedure will be counterbalanced.
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes
Inclusion criteria
: * Newly admitted patients to the Oklahoma State University Behavioral Medicine Clinic
Exclusion criteria
* Vulnerable populations, such as children (i.e., minors or individuals under the legal age of consent) and individuals who are incarcerated (i.e., prisoners), will be excluded. * Individuals who are not their own guardian (i.e., those suffering from severe disabilities) will also be excluded.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| GAD 7 Diagnostic Scores | Five minutes | Scores from the self administered assessment for general anxiety disorder |
| User Experience Questionnaire | Five minutes | Likert based questionnaire on user experience |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Patient's Qualitative Responses | One minute | Comments from patient on usability of the device |
Countries
United States
Contacts
Primary ContactJason Beaman, D.O.
Backup ContactLuke Lawson, M.A.
Outcome results
None listed